Clinical Trial Update: A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder. [Phase 3]

View source ↗

Summary

A Phase 3 study of an investigational drug for major depressive episodes associated with Bipolar I Disorder was terminated, with results posted on 2024-09-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Unspecified investigational drug

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Depressive Episodes, Bipolar I Depression | Phase 3 | Status: TERMINATED | Results posted: 2024-09-19